Vicarious Surgical reported a significant 35% reduction in operating expenses in Q3 2025, leading to a narrowed net loss compared to the same period last year, as the company focuses on achieving design freeze for its surgical system by year-end 2026.

• Total operating expenses decreased to $11.5 million, down from $17.8 million in Q3 2024.
• GAAP net loss narrowed to $11.1 million ($1.86 per share) from $17.1 million ($2.90 per share) year-over-year.
• Successful fundraising added approximately $5.2 million in net proceeds, bolstering the balance sheet as cash burn reduction efforts are emphasized.
• Management is implementing targeted outsourcing to improve capital efficiency while preserving innovation in critical technology areas.